1. Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, the Netherlands;
2. Novartis, Arnhem, the Netherlands;
3. Arons Consultancy, Rosmalen, the Netherlands;
4. IQVIA, Real World Evidence Solutions and Health Economic Outcomes Research, Amsterdam, the Netherlands